Net profit of Beryl Drugs declined 96.30% to Rs 0.01 crore in the quarter ended September 2024 as against Rs 0.27 crore during the previous quarter ended September 2023. Sales declined 30.14% to Rs 5.61 crore in the quarter ended September 2024 as against Rs 8.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.618.03 -30 OPM %9.988.97 - PBDT0.440.62 -29 PBT0.110.33 -67 NP0.010.27 -96 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live News

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 September 2024.Powered by Capital Market - Live News